{
    "clinical_study": {
        "@rank": "163267", 
        "arm_group": [
            {
                "arm_group_label": "PluroGel", 
                "arm_group_type": "Placebo Comparator", 
                "description": "PluroGel"
            }, 
            {
                "arm_group_label": "PluroGel N", 
                "arm_group_type": "Experimental", 
                "description": "PluroGel N"
            }
        ], 
        "brief_summary": {
            "textblock": "This will be a randomized, double-blind (evaluator-blind), vehicle-controlled study of 50\n      enrolled subjects. Adult subjects (greater than 18 years old) who present with a mildly\n      infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis\n      but not involving joint capsule, tendon, and bone). Subjects must also provide informed\n      consent and meet all other entry criteria to be enrolled and randomly assigned to receive\n      PluroGel N or PluroGel vehicle."
        }, 
        "brief_title": "Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetic Foot Ulcer", 
            "Infection"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Ulcer", 
                "Foot Ulcer", 
                "Diabetic Foot"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Non-hospitalized subjects with Type 1 or Type 2 diabetes mellitus as defined by the\n             American Diabetes Association diagnostic criteria (ADA, 2010). Diabetes may be\n             treated with insulin, oral hypoglycemic agents, diet, or a combination of these\n             therapies. Subjects whose diabetes is considered \"controlled\" by diet or medication\n             in the opinion of the physician.\n\n               -  Males or females at least 18 years old.\n\n               -  Subjects must be considered by the investigator to be reliable, willing and able\n                  to give signed informed consent, and must sign the informed consent form.\n\n               -  Subjects must have a full thickness (i.e., extending through dermis but not\n                  involving tendon, bone, or joint capsule) ulcer on the foot distal to the\n                  malleoli with a surface area \u22651 cm2 after the wound has undergone appropriate\n                  debridement. Subjects must have localized mild infection of the ulcer, as\n                  defined by the IDSA criteria as per Appendix C, with in the PGN1300 Protocol,\n                  which the investigator believes would ordinarily be treated on an outpatient\n                  basis.\n\n        IDSA mild infection of an ulcer is defined as:\n\n        The presence of \u22652 of the following items:\n\n          -  Local swelling or induration\n\n          -  Erythema\n\n          -  Local tenderness or pain\n\n          -  Local warmth\n\n          -  Purulent discharge (thick, opaque to white or sanguineous secretion) Local infection\n             involving only the skin and the subcutaneous tissue. If erythema, must be >0.5 cm to\n             \u22642 cm around the ulcer.\n\n               -  Diabetic Foot Infection-General Parameters Score of at least 2 must be obtained\n                  in order to be eligible for enrollment.\n\n               -  Diabetic Foot Infection-Wound Size Score of at least 1 must be obtained in order\n                  to be eligible for enrollment.\n\n               -  The diagnosis of mild infection must be confirmed immediately following the Day\n                  0 (Enrollment Visit) debridement, although pre-debridement purulence is to be\n                  counted as one manifestation of infection.\n\n        Exclusion Criteria:\n\n          -  Subjects with IDSA-defined moderate infection as per Appendix C, including cellulitis\n             extending > 2 cm; lymphangitis; spread beneath the fascia; deep tissue abscess;\n             osteomyelitis; gangrene; muscle, joint, or bone involvement.\n\n               -  Subjects with IDSA-defined severe infection as per Appendix C, within PGN1300\n                  Protocol including systemic toxicity or metabolic instability (e.g., fever,\n                  chills, tachycardia, hypotension, confusion, vomiting, leukocytosis, acidosis,\n                  hyperglycemia, or azotemia).\n\n               -  Subjects with systemic inflammatory response signs, as manifested by \u22652 of the\n                  following :\n\n          -  Temperature >38\u00b0C or <36\u00b0C\n\n          -  Heart rate >90 beats/min\n\n          -  Respiratory rate >20 breaths/min or PaCO2 <32 mm Hg\n\n          -  White blood cell count >12 000 or <4000 cells/\u03bcL or \u226510% immature (band) forms\n\n               -  Subjects with local wound complications (e.g., prosthetic materials).\n\n               -  Subjects currently receiving antibiotic treatment for a localized infection of\n                  the study ulcer and whose infection is improving in response to treatment.\n\n               -  Subjects requiring concurrent systemic antimicrobials during the study period\n                  for any infection, including diabetic foot ulcer.\n\n               -  Subjects in whom bone or joint involvement is suspected based on clinical\n                  examination (e.g., bone noted visually or by probing) or plain view X-ray.\n\n               -  Subjects with clinically significant peripheral arterial disease requiring\n                  vascular reconstructive surgery. Subjects who are expected to be unable to care\n                  for their ulcer because of hospitalization, vacation, disability, etc. during\n                  the study period, or are unable to safely monitor the infection status at home.\n\n               -  Subjects with known active alcohol or substance abuse within the 6 months\n                  preceding study entry.\n\n               -  Subjects who are receiving immunosuppressive agents (other than\n                  corticosteroids), radiation therapy, or cytotoxic agents.\n\n               -  Subjects who require treatment for a primary or metastatic malignancy (other\n                  than squamous or basal cell carcinoma of the skin).\n\n               -  Subjects with a systemically immunocompromising disease, such as acquired immune\n                  deficiency syndrome or known human immunodeficiency virus infection.\n\n               -  Subjects who have had an unexplained fever or chills during the week prior to\n                  enrollment.\n\n               -  Subjects with other conditions considered by the investigator to be reasons for\n                  disqualification that may jeopardize subject safety or interfere with the\n                  objectives of the trial (e.g., acute illness or exacerbation of chronic illness,\n                  lack of motivation, history of poor compliance).\n\n               -  Subjects with any known allergy or other contraindication to any ingredients in\n                  the study products.\n\n               -  Women who are breast feeding, pregnant, or not using contraception unless\n                  sterile.\n\n               -  Subjects who have been taking or expect to be taking any other investigational\n                  therapy within the 30 days prior to entry or during enrollment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02091596", 
            "org_study_id": "PGN-1300", 
            "secondary_id": "D11AC00020"
        }, 
        "intervention": [
            {
                "arm_group_label": "PluroGel N", 
                "description": "Study Drug", 
                "intervention_name": "PluroGel N", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "PluroGel", 
                "description": "PluroGel Vehicle Placebo Comparator", 
                "intervention_name": "PluroGel", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Wound", 
            "Ulcer", 
            "Infected", 
            "Infection"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": [
            {
                "contact": {
                    "email": "sunigmka@aol.com", 
                    "last_name": "Suni Allen", 
                    "phone": "213-365-0793"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90010"
                    }, 
                    "name": "Foot & Ankle Clinic"
                }, 
                "investigator": {
                    "last_name": "Felix Sigal, DPM", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kedmunds@SamuelMerritt.edu", 
                    "last_name": "Kathleen Edmunds", 
                    "phone": "510-869-6511", 
                    "phone_ext": "7564"
                }, 
                "facility": {
                    "address": {
                        "city": "Oakland", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94609"
                    }, 
                    "name": "Samuel Merritt University"
                }, 
                "investigator": [
                    {
                        "last_name": "Tim Dutra, DPM", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Kevin Miller, DPM", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "phoenix_medical_research@hotmail.com", 
                    "last_name": "Teresa Vadles", 
                    "phone": "786-762-2040"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33165"
                    }, 
                    "name": "Phoenix Medical Research, LLC"
                }, 
                "investigator": [
                    {
                        "last_name": "Oscar Barreto, DPM", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Jose M Birriel, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ggonzalez@arkios.com", 
                    "last_name": "Glenda Gonzalez", 
                    "phone": "305-971-9827"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33186"
                    }, 
                    "name": "Med Research of Florida, LCC"
                }, 
                "investigator": [
                    {
                        "last_name": "Joaquin Fernandez, DPM", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Carlos Verdeza, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jorge L Valdes, DPM", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Carlos A Verdeza, PA", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jdellis300@gmail.com", 
                    "last_name": "John Ellis", 
                    "phone": "305-484-0498"
                }, 
                "contact_backup": {
                    "email": "s.rodriguez@mcclinicalresearch.com", 
                    "last_name": "Suzi Rodriguez", 
                    "phone": "305-484-0498"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33144"
                    }, 
                    "name": "Miami Center for Clinical Research, LLC"
                }, 
                "investigator": [
                    {
                        "last_name": "Luis De Armas, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Blanca N Gonzalez, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "info@sweethoperesearchspecialty.com", 
                    "last_name": "Yoany Chavez", 
                    "phone": "305-456-9062"
                }, 
                "contact_backup": {
                    "email": "Yoany_Chavez@yahoo.com", 
                    "last_name": "Yoany Chavez"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami Lakes", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33016"
                    }, 
                    "name": "Sweet Hope Research Specialty, Inc."
                }, 
                "investigator": [
                    {
                        "last_name": "Ivan Rodriguez, DO, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Gilberto J Acosta, DPM", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "iputowska@weil4feet.com", 
                    "last_name": "Iwona Putowska", 
                    "phone": "847-390-7666"
                }, 
                "facility": {
                    "address": {
                        "city": "Des Plaines", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60016"
                    }, 
                    "name": "Weil Foot & Ankle Institute"
                }, 
                "investigator": [
                    {
                        "last_name": "Lowell S Weil, SR, DPM", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "George Enriquez, DPM", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jeffrey Baker, DPM", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Gregory Amarantos, DPM", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Erin Klein, DPM", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Michael Bowen, DPM", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Adam Fleischer, DPM", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hirakbrouth@gmail.com", 
                    "last_name": "Hirak B Routh", 
                    "phone": "215-563-7330"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19103"
                    }, 
                    "name": "Paddington Testing Company, Inc"
                }, 
                "investigator": [
                    {
                        "last_name": "Jennifer L Parish, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Lawrence C Parish, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Hirak B Routh, MBBS", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Kazal R Routh, MBBS", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "cgp108@aol.com", 
                    "last_name": "Kathleen McGee", 
                    "phone": "757-523-0414"
                }, 
                "contact_backup": {
                    "email": "pagnw@aol.com", 
                    "last_name": "Patrick Agnew, DPM", 
                    "phone": "757-523-0414"
                }, 
                "facility": {
                    "address": {
                        "city": "Virginia Beach", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23464"
                    }, 
                    "name": "Coastal Podiatry Group"
                }, 
                "investigator": [
                    {
                        "last_name": "Patrick Agnew, DPM", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Lynette M Santiago, DPM", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Double-blind, Vehicle-controlled 2-Arm Trial of Topical PluroGel N for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300", 
        "overall_contact": {
            "email": "gpekoe@arkios.com", 
            "last_name": "Gary Pekoe, Pharmacology & Toxicology", 
            "phone": "7576182300"
        }, 
        "overall_contact_backup": {
            "email": "tprice@arkios.com", 
            "last_name": "Terrah Price, Business Management & Admin."
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical Response is defined by the investigator's evaluation of the signs and symptoms of clinical infection.", 
            "measure": "Clinical Response", 
            "safety_issue": "No", 
            "time_frame": "14 Days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02091596"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "PluroGen Therapeutics, Inc", 
        "sponsors": {
            "collaborator": {
                "agency": "Arkios BioDevelopment International", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "PluroGen Therapeutics, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}